title: The concentrations of collagen-associated amino acids are higher in GnRH agonist-treated uterine myomas.
abstract: OBJECTIVE
  To test the hypothesis that the effects of estrogen reduction on uterine leiomyoma regression are mediated through changes in cell density or the extracellular matrix.
  
  
  METHODS
  Uterine myomas were obtained from 20 women who had received randomly either the GnRH agonist leuprolide acetate depot for 3 months or placebo. The biochemical and morphologic characteristics studied included: total protein, DNA, and amino acid concentrations; histologic appearance; collagen content; and nuclear density.
  
  
  RESULTS
  The absolute and relative concentrations of hydroxylysine, hydroxyproline, glycine, and proline were significantly greater (P < .05) in uterine myomas from patients pretreated with a GnRH agonist compared with placebo-treated controls. The GnRH agonist was also associated with trends toward increased mean total protein, DNA, and nuclear density, but the differences did not reach statistical significance.
  
  
  CONCLUSIONS
  The concentrations of the amino acids contained in collagen were significantly greater in uterine myomas from patients treated with the GnRH agonist compared to myomas from placebo-treated controls. In addition, our observations suggest that the reduction in uterine myoma volume associated with GnRH agonist therapy is associated with alterations in the extracellular matrix.
authors.affiliation: Department of Obstetrics, Gynecology, and Reproductive Biology, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts.
authors.forename: M S
authors.initials: MS
authors.lastname: Rein
authors.forename: R L
authors.initials: RL
authors.lastname: Barbieri
authors.forename: W
authors.initials: W
authors.lastname: Welch
authors.forename: R E
authors.initials: RE
authors.lastname: Gleason
authors.forename: J P
authors.initials: JP
authors.lastname: Caulfield
authors.forename: A J
authors.initials: AJ
authors.lastname: Friedman
mesh_terms: D000596:Amino Acids / Q000032:analysis; D003094:Collagen / Q000032:analysis* / Q000096:biosynthesis; D004273:DNA, Neoplasm / Q000032:analysis; D004311:Double-Blind Method; D005260:Female; D006801:Humans; D007889:Leiomyoma / Q000737:chemistry / Q000188:drug therapy* / Q000378:metabolism / Q000473:pathology; D016729:Leuprolide / Q000627:therapeutic use*; D014594:Uterine Neoplasms / Q000737:chemistry / Q000188:drug therapy* / Q000378:metabolism / Q000473:pathology
chemical_list: D000596:Amino Acids; D004273:DNA, Neoplasm; D003094:Collagen; D016729:Leuprolide